688091

Shanghai Yizhong Pharmaceutical XSSC:688091 Stock Report

Last Price

CN¥57.24

Market Cap

CN¥9.1b

7D

2.0%

1Y

n/a

Updated

28 Nov, 2023

Data

Company Financials

Shanghai Yizhong Pharmaceutical Co., Ltd.

XSSC:688091 Stock Report

Mkt Cap: CN¥9.1b

Shanghai Yizhong Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Shanghai Yizhong Pharmaceutical
Historical stock prices
Current Share PriceCN¥57.24
52 Week HighCN¥93.00
52 Week LowCN¥48.60
Beta-0.93
1 Month Change3.60%
3 Month Change-5.37%
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO-35.86%

Recent News & Updates

Recent updates

Shareholder Returns

688091CN PharmaceuticalsCN Market
7D2.0%0.3%-1.8%
1Yn/a0.2%-5.2%

Return vs Industry: Insufficient data to determine how 688091 performed against the CN Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how 688091 performed against the CN Market.

Price Volatility

Is 688091's price volatile compared to industry and market?
688091 volatility
688091 Average Weekly Movement6.4%
Pharmaceuticals Industry Average Movement4.6%
Market Average Movement4.6%
10% most volatile stocks in CN Market8.3%
10% least volatile stocks in CN Market2.9%

Stable Share Price: 688091 is more volatile than 75% of CN stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: 688091's weekly volatility (6%) has been stable over the past year, but is still higher than 75% of CN stocks.

About the Company

FoundedEmployeesCEOWebsite
2009243Jingsong Zhouhttps://www.yizhongpharma.com

Shanghai Yizhong Pharmaceutical Co., Ltd. engages in the development of anti-tumor drugs and related products in China. It develops a dosage form of paclitaxel, an anti-tumor chemotherapeutic. Shanghai Yizhong Pharmaceutical Co., Ltd.

Shanghai Yizhong Pharmaceutical Co., Ltd. Fundamentals Summary

How do Shanghai Yizhong Pharmaceutical's earnings and revenue compare to its market cap?
688091 fundamental statistics
Market CapCN¥9.06b
Earnings (TTM)CN¥169.31m
Revenue (TTM)CN¥348.83m

53.5x

P/E Ratio

26.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
688091 income statement (TTM)
RevenueCN¥348.83m
Cost of RevenueCN¥24.09m
Gross ProfitCN¥324.75m
Other ExpensesCN¥155.43m
EarningsCN¥169.31m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)1.07
Gross Margin93.09%
Net Profit Margin48.54%
Debt/Equity Ratio1.4%

How did 688091 perform over the long term?

See historical performance and comparison

Dividends

0.5%

Current Dividend Yield

25%

Payout Ratio